查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2033033

全球水痘疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Varicella Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 260 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球水痘疫苗市場預計將從2025年的42.2億美元成長至2034年的77.7億美元，2026年至2034年的複合年成長率（CAGR）為7.02%。該市場正經歷強勁成長，主要得益於人們對疫苗接種和感染疾病預防意識的不斷提高。水痘疫苗用於預防水痘，水痘是一種傳染性極強的病毒感染疾病。各國政府和衛生機構實施的疫苗接種計畫是市場擴張的主要驅動力。此外，人們對預防性醫療保健的日益重視也促進了全球疫苗的推廣應用。

推動市場成長的關鍵因素包括健康意識的提高和免疫接種計劃的擴大。世界各國政府都在加大對免疫接種宣傳活動的投入，以降低感染疾病的發生率。疫苗供應和分銷網路的改善也促進了市場成長。此外，疫苗研發的進步提高了疫苗的有效性和安全性，從而促進了疫苗的更廣泛應用。

展望未來，對醫療保健和研發的持續投入預計將對市場產生正面影響。聯合疫苗的研發和儲存方案的改進將提高疫苗的供應量。新興市場醫療基礎設施的完善和公眾意識的提高預計將帶來顯著成長。隨著全球預防感染疾病工作的持續推進，水痘疫苗市場有望實現永續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球水痘疫苗市場：依疫苗類型分類

  • 市場分析、洞察與預測
  • 單抗原水痘疫苗
  • 綜合水痘疫苗

第5章 全球水痘疫苗市場：依應用分類

  • 市場分析、洞察與預測
  • 水痘疫苗
  • 腮腺炎、麻疹、德國德國麻疹及水痘疫苗（MMRV）

第6章 全球水痘疫苗市場：依年齡層別分類

  • 市場分析、洞察與預測
  • 兒童
  • 青少年和成人

第7章 全球水痘疫苗市場：依採購方式分類

  • 市場分析、洞察與預測
  • 公部門
  • 私人的

第8章 全球水痘疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Bio-Med
    • Changchun Changsheng Life Sciences Limited
    • GC Pharma
    • GlaxoSmithKline
    • Merck
    • Mitsubishi Tanabe Pharma Corporation
    • Novo Medi Sciences
    • Sanofi
    • Seqirus
    • Sinovac Biotech
    • SK Bioscience
    • Takeda Pharmaceutical Company Limited
簡介目錄
Product Code: VMR11218547

The global varicella vaccines market size is expected to reach USD 7.77 Billion in 2034 from USD 4.22 Billion in 2025, growing at a CAGR of 7.02 during 2026-2034.This market is experiencing strong growth driven by increasing awareness about immunization and the prevention of infectious diseases. Varicella vaccines are used to protect against chickenpox, a highly contagious viral infection. The implementation of vaccination programs by governments and healthcare organizations is a major factor contributing to market expansion. Additionally, the growing focus on preventive healthcare is encouraging the adoption of vaccines across various regions.

Major drivers include rising healthcare awareness and the expansion of immunization programs. Governments are investing in vaccination campaigns to reduce the incidence of infectious diseases. The increasing availability of vaccines and improved distribution networks are also supporting market growth. Furthermore, advancements in vaccine development are enhancing efficacy and safety, encouraging wider adoption.

Looking ahead, the market is expected to benefit from continued investments in healthcare and research. The development of combination vaccines and improved storage solutions will enhance accessibility. Emerging markets are likely to witness significant growth due to increasing healthcare infrastructure and awareness. As global efforts to prevent infectious diseases continue, the varicella vaccines market is set for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Vaccine Type

  • Monovalent Varicella Vaccine
  • Combination Varicella Vaccine

By Application

  • Chickenpox Immunization
  • Mumps, Measles, Rubella, and Varicella (MMRV) Immunization

By Age Group

  • Pediatrics
  • Adolescents and Adults

By Procurement

  • Public
  • Private

COMPANIES PROFILED

  • Bio-Med, Changchun Changsheng Life Sciences Limited, GC Pharma, GlaxoSmithKline, Merck, Mitsubishi Tanabe Pharma Corporation, Novo Medi Sciences, Sanofi, Seqirus, Sinovac Biotech, SK Bioscience, Takeda Pharmaceutical Company Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VARICELLA VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Vaccine Type
  • 4.2. Monovalent Varicella Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Combination Varicella Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL VARICELLA VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Chickenpox Immunization Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Mumps, Measles, Rubella, and Varicella (MMRV) Immunization Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL VARICELLA VACCINES MARKET: BY AGE GROUP 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast Age Group
  • 6.2. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Adolescents and Adults Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL VARICELLA VACCINES MARKET: BY PROCUREMENT 2022-2034 (USD MN and Million Doses)

  • 7.1. Market Analysis, Insights and Forecast Procurement
  • 7.2. Public Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.3. Private Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL VARICELLA VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.2.1 By Vaccine Type
    • 8.2.2 By Application
    • 8.2.3 By Age Group
    • 8.2.4 By Procurement
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.3.1 By Vaccine Type
    • 8.3.2 By Application
    • 8.3.3 By Age Group
    • 8.3.4 By Procurement
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.4.1 By Vaccine Type
    • 8.4.2 By Application
    • 8.4.3 By Age Group
    • 8.4.4 By Procurement
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.5.1 By Vaccine Type
    • 8.5.2 By Application
    • 8.5.3 By Age Group
    • 8.5.4 By Procurement
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.6.1 By Vaccine Type
    • 8.6.2 By Application
    • 8.6.3 By Age Group
    • 8.6.4 By Procurement
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VARICELLA VACCINES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Bio-Med
    • 10.2.2 Changchun Changsheng Life Sciences Limited
    • 10.2.3 GC Pharma
    • 10.2.4 GlaxoSmithKline
    • 10.2.5 Merck
    • 10.2.6 Mitsubishi Tanabe Pharma Corporation
    • 10.2.7 Novo Medi Sciences
    • 10.2.8 Sanofi
    • 10.2.9 Seqirus
    • 10.2.10 Sinovac Biotech
    • 10.2.11 SK Bioscience
    • 10.2.12 Takeda Pharmaceutical Company Limited